Skip to main content

Genetic Technologies Settles Junk DNA Patent Suit with Nuvelo and Covance, but not Applera

NEW YORK, Nov. 18 (GenomeWeb News) - Genetic Technologies of Melbourne, Australia, said today that it has settled lawsuits filed against Nuvelo and Covance for infringement of its non-coding DNA patents.

Genetic Technologies initiated legal action against the two companies and Applera in April 2003.

In a statement today, the company said it "will now dismiss the actions against Nuvelo and Covance," and "plans to "focus its efforts on the remaining action against Applera Corporation."

Specific terms of the settlements were not provided.

The company said it also plans to continue "global expansion of the out-licensing of the GTG non-coding patents" - a controversial strategy that has drawn criticism from the scientific community over the past year.

Genetic Technologies has claimed to be in negotiations with 60 potential licensees worldwide. Licensees and cross-licensees for the company's patents include Orchid Biosciences, Pyrosequencing, Nanogen, and Myriad.  

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.